BioCentury
ARTICLE | Company News

Pharmagene, GSK discovery technology deal

September 16, 2004 7:00 AM UTC

Pharmagene (LSE:PGN) granted GlaxoSmithKline (LSE:GSK; GSK) access to PGN's Phase Zero lead identification and optimization technology. All of GSK's seven global Centers of Excellence for Drug Discove...